UCMSC Transplantation in the Treatment of Cartilage Damage

NCT02776943 · Status: UNKNOWN · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2016-05-18

No results posted yet for this study

Summary

The purpose of this study is to investigate the efficacy and safety of transplantation of umbilical cord mesenchymal stem cells(UCMSCs) in patient with Knee cartilage damage.

Conditions

  • Cartilage Damage
  • Degenerative Osteoarthritis

Interventions

BIOLOGICAL

umbilical cord mesenchymal stem cells

DEVICE

Hyaluronic acid

Sponsors & Collaborators

  • South China Research Center for Stem Cell and Regenerative Medicine

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-06-30
Primary Completion
2018-12-31
Completion
2019-06-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02776943 on ClinicalTrials.gov